Enduring effects of Preventive Cognitive Therapy in adults remitted from recurrent depression: A 10 year follow-up of a randomized controlled trial

Journal of Affective Disorders

Volumn 185, Issue , 2015, Pages 188-194

  Bockting, Claudi L H ^a,b   Smid, N Heleen ^c   Koeter, Maarten W J ^c   Spinhoven, Philip ^d   Beck, Aaron T ^e   Schene, Aart H ^f,g  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d LEIDEN UNIVERSITY   (Netherlands)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g RADBOUD UNIVERSITY   (Netherlands)

Author keywords

Cognitive therapy; Continuation treatment; Depressive disorder; Long term effects; Maintenance; Prevention; Randomized controlled trial; Relapse recurrence

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; ATTITUDE SCALE; COGNITIVE THERAPY; DISEASE SEVERITY; DSM-IV; FEMALE; FOLLOW UP; HAMILTON DEPRESSION RATING SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTCOME ASSESSMENT; PATIENT COUNSELING; PREVENTIVE COGNITIVE THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RECURRENT DISEASE; REMISSION; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SURVIVAL RATE; SURVIVAL TIME; AGED; CONTROLLED STUDY; DEPRESSIVE DISORDER, MAJOR; MIDDLE AGED; PATIENT DROPOUTS; PERSONALIZED MEDICINE; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADULT; AGED; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT DROPOUTS; PRECISION MEDICINE; RECURRENCE; SECONDARY PREVENTION; TREATMENT OUTCOME;

EID: 84937554338     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2015.06.048     Document Type: Article

References (42)

1. American Psychiatric Association Practice Guideline for the treatment of patients with Major Depressive Disorder third edition 2010 American Psychiatric Association Arlington, VA
2. A.T. Beck, A.J. Rush, B.F. Shaw, and G. Emery Cognitive Therapy of Depression 1979 Guilford Press New York, NY
3. S. Beshai, K.S. Dobson, C.L.H. Bockting, and L. Quigley Relapse and recurrence prevention in depression: current research and future prospects Clin. Psychol. Rev. 8 2011 10.1016/j.cpr.2011.09.003 1349-60
4. C.L. Bockting, P. Spinhoven, L.F. Wouters, M.W. Koeter, A.H. Schene DELTA Study Group Long-term effects of preventive cognitive therapy in recurrent depression: a 5.5-year follow-up study J. Clin. Psychiatry 70 2009 10.4088/JCP.08m04784blu 1621-8
5. C.L.H. Bockting, M.C. ten Doesschate, J. Spijker, Ph Spinhoven, A.H. Schene DELTA Study Group Continuation and maintenance use of antidepressants in recurrent depression Psychoth. Psychosom. 77 2008 17 26 PMID:18087204
6. C.L.H. Bockting, A.H. Schene, P. Spinhoven, M.W. Koeter, L.F. Wouters, J. Huyser, and J.H. Kamphuis Preventing recurrence in recurrent depression using cognitive therapy J. Consult. Clin. Psychol. 73 2005 647 657 PMID:16173852
7. Bockting, C.L.H., Kok, G.D., van der Kamp, L., Smit, F., van Valen, E., Schoevers, R., van Marwijk, H., Cuijpers, P., Riper, H., Dekker, J., Beck, A.T., 2011. Disrupting the rhythm of depressionusing Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocol. BMC Psychiatry. 11 (14)11-12. doi: 10.1186/1471-244X-11-12.
8. P. Cuijpers, S.D. Hollon, A. van Straten, M. Berking, C.L.H. Bockting, and G. Andersson Does cognitive behaviour therapy have an enduring effect that is superior to keeping patients on continuation medication? A meta-analysis BMJ open 26 4 2013 10.1136/bmjopen-2012-002542 pii: e002542.
9. K.S. Dobson, S.D. Hollon, S. Dimidjian, K.B. Schmaling, R.J. Kohlenberg, R. Gallop, S.L. Rizvi, J.K. Gollan, D.L. Dunner, and N.S. Jacobson Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression J. Consult. Clin. Psychol. 76 2008 10.1037/0022-006X.76.3.468 468-77
10. W.W. Eaton, H. Shao, G. Nestadt, H.B. Lee, O.J. Bienvenu, and P. Zandi Population-based study of first onset and chronicity in major depressive disorder Arch. Gen. Psychiatry 65 2008 10.1001/archpsyc.65.5.513 513-20
11. G.A. Fava, C. Rafanelli, S. Grandi, R. Canestrari, and M.A. Morphy Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression Am. J. Psychiatry 155 1998 1443 1445 PMID:9766780
12. G.A. Fava, C. Ruini, C. Rafanelli, L. Finos, S. Conti, and S. Grandi Six-year outcome of cognitive behavior therapy for prevention of recurrent depression Am. J. Psychiatry 161 2004 1872 1876 PMID:15465985
13. M.B. First, M. Gibbon, R.L. Spitzer, and Williams JBW User Guide for the Structured Clinical Interview for DSM-IV Axis 1 Disorders 1996 American Psychiatric Association Washington, DC
14. J.R. Geddes, S.M. Carney, C. Davies, T.A. Furukawa, D.J. Kupfer, E. Frank, and G.M. Goodwin Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review Lancet 361 9358 2003 653 661 PMID:12606176
15. P. Glue, M.R. Donovan, S. Kolluri, and B. Emir Meta-analysis of relapse prevention antidepressant trials in depressive disorders Aust. N. Z. J. Psychiatry 44 2010 697 705 10.3109/00048671003705441
16. G. Guidi, G.A. Fava, M. Fava, and G.I. Papakostas Efficacy of sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysis Psychol. Med. 10 2010 1 11 10.1017/S0033291710000826. Epub 2010 May 6
17. L. Hakkaart-van Roijen, A. van Straten, M. Donker, and B. Tiemens Manual Trimbos/IMTA Questionnaire for Costs Associated with Psychiatric Illness (TIC-P) 2002, Institute for Medical Technology Assessment, Erasmus University Rotterdam
18. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
19. R. Hansen, B. Gaynes, P. Thieda, G. Gartlehner, A. Deveaugh-Geiss, E. Krebs, and K. Lohr Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants Psychiatr. Serv. 59 2008 1121 1130 10.1176/appi.ps.59.10.1121
20. F. Holländare, S. Johnsson, M. Randestad, M. Tillfors, P. Carlbring, G. Andersson, and I. Engström Randomized trial of Internet-based relapse prevention for partially remitted depression Acta Psychiatr. Scand. 124 2011 285 294 10.1111/j.1600-0447.2011.01698.x
21. S.D. Hollon, R.J. DeRubeis, R.C. Shelton, J.D. Amsterdam, R.M. Salomon, J.P. O'Reardon, M.L. Lovett, P.R. Young, K.L. Haman, B.B. Freeman, and R. Gallop Prevention of relapse following cognitive therapy vs medications in moderate to severe depression Arch. Gen. Psychiatry 62 2005 417 427 PMID:15809409
22. Z.E. Imel, M.B. Malterer, K.M. McKay, and B.E. Wampold A meta-analysis of psychotherapy and medication in unipolar depression and dysthymia J. Affect. Disord. 110 2008 197 206 10.1016/j.jad.2008.03.018 (Epub 2008 May 5)
23. R.B. Jarrett, D. Kraft, J. Doyle, B.M. Foster, G.G. Eaves, and P.C. Silver Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial Arch. Gen. Psychiatry 58 4 2001 381 388
24. N. Kaymaz, J. van Os, A.J. Loonen, and W.A. Nolen Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials J. Clin. Psychiatry 69 2008 1423 1436 PMID:19193343
25. R.C. Kessler, W.T. Chiu, O. Demler, K.R. Merikangas, and E.E. Walters Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication Arch. Gen. Psychiatry 62 2005 617 627
26. G. Kok, H. Burger, H. Riper, P. Cuijpers, J. Dekker, H. vanMarwijk, F. Smit, A. Beck, and C.L. Bockting The three-month effect of mobile internet-based cognitive therapy on the course of depressive symptoms in remitted recurrently depressed patients: results of a randomized controlled trial Psychoth. Psychosom. 21 84 2 2015 90 99
27. D.J. Kupfer, E. Frank, and M.L. Phillips Major depressive disorder: new clinical, neurobiological, and treatment perspectives Lancet 17 2012 1045 1055 10.1016/S0140-6736(11)60602-8
28. W. Kuyken, S. Byford, R.S. Taylor, E. Watkins, E. Holden, K. White, B. Barrett, R. Byng, A. Evans, E. Mullan, and J.D. Teasdale Mindfulness-based cognitive therapy to prevent relapse in recurrent depression J. Consult. Clin. Psychol. 76 2008 966 978 10.1037/a0013786
29. C.D. Mathers, and D. Loncar Projections of global mortality and burden of disease from 2002 to 2030 PLoS Med. 3 2006 442 PMID:16899150
30. C.D. Mathers, A.D. Lopez, and C.J.L. Murray The burden of disease and mortality by condition: data, methods, and results for 2001 A.D. Lopez, C.D. Mathers, M. Ezzati, D.T. Jamison, C.J.L. Murray, Global Burden of Disease and Risk Factors 2006 World Bank Washington (DC) (Chapter 3. PMID: 21250373)
31. T.E. Moffitt, A. Caspi, A. Taylor, J. Kokaua, B.J. Milne, G. Polanczyk, and R. Poulton How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment Psychol. Med. 40 2010 899 909 10.1017/S0033291709991036 (Epub 2009 Sep 1)
32. National Institute for Health and Clinical Excellence Depression: Management of Depression in Adults. Clinical Practice Guideline updated edition 2010 National Institute for Clinical Excellence London
33. S. Oestergaard, and C. Moldrup Optimal duration of combined psychotherapy and pharmacotherapy for patients with moderate and severe depression: a meta-analysis J. Affect. Disord. 131 2011 24 36 10.1016/j.jad.2010.08.014 (Epub 2010 Oct 14)
34. M. Olfson, and S.C. Marcus National patterns in antidepressant medication treatment Arch. Gen. Psychiatry 66 2009 848 856 10.1001/archgenpsychiatry.2009.81
35. E.S. Paykel, J. Scott, P.L. Cornwall, R. Abbott, C. Crane, M. Pope, and A.L. Johnson Duration of relapse prevention after cognitive therapy in residual depression: follow-up of controlled trial Psychol. Med. 35 2005 59 68 PMID: 15842029
36. J. Piet, and E. Hougaard The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis Clin. Psychol. Rev. 31 2011 1032 1040 10.1016/j.cpr.2011.05.002 (Review; Epub 2011 May 15)
37. H.E. Pigott, A.M. Leventhal, G.S. Alter, and J.J. Boren Efficacy and effectiveness of antidepressants: current status of research Psychother. Psychosom. 79 2010 267 279 10.1159/000318293 (Review; Epub 2010 Jul 9)
38. Z.V. Segal, P. Bieling, T. Young, G. MacQueen, R. Cooke, L. Martin, R. Bloch, and R.D. Levitan Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression Arch. Gen. Psychiatry 6 2010 1256 1264 10.1001/archgenpsychiatry.2010.168
39. D.A. Solomon, M.B. Keller, A.C. Leon, T.I. Mueller, P.W. Lavori, M.T. Shea, W. Coryell, M. Warshaw, C. Turvey, J.D. Maser, and J. Endicott Multiple recurrences of major depressive disorder Am. J. Psychiatry 157 2000 229 233 PMID:10671391
40. U. Stangier, C. Hilling, T. Heidenreich, A.K. Risch, A. Barocka, R. Schlösser, K. Kronfeld, C. Ruckes, H. Berger, J. Röschke, F. Weck, S. Volk, M. Hambrecht, R. Serfling, R. Erkwoh, A. Stirn, T. Sobanski, and M. Hautzinger Maintenance cognitive-behavioral therapy and manualized psychoeducation in the treatment of recurrent depression: a multicenter prospective randomized controlled trial Am. J. Psychiatry 170 6 2013 624 632 10.1176/appi.ajp.2013.12060734
41. J.R. Vittengl, L.A. Clark, T.W. Dunn, and R.B. Jarrett Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects J. Consult. Clin. Psychol. 75 2007 475 488 PMID: 17563164
42. World Medical Association World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects J. Am. Med. Assoc. 284 2000 3043 3045 10.1001/jama.284.23.3043